Michael Clayman

Michael Clayman

Presidente presso
Anokion SA
74 anni
Health Technology
Consumer Services
Industrial Services

Profilo

Michael D.
Clayman
is the founder of Flexion Therapeutics, Inc., which was founded in 2007.
He held the title of President, Chief Executive Officer & Director from 2018 to 2021.
Currently, he is the Non-Executive Chairman at Anokion SA since 2016, Chairman at Ribometrix, Inc. since 2019, Chairman at Nido Biosciences, Inc. since 2022, and Director at Kanyos Bio, Inc. He previously worked as an Independent Director at Akebia Therapeutics, Inc. from 2014 to 2018.
He also held positions at Eli Lilly & Co., Abbott Cardiovascular Systems, Inc., Chorus Group Ltd., Lilly Research Laboratories, and Perelman School of Medicine.
He completed his undergraduate degree at Yale University and obtained a doctorate from UC San Diego School of Medicine.

Posizioni attive di Michael Clayman

SocietàPosizioneInizio
Presidente 14/06/2018
Direttore/Membro del Consiglio -
Presidente 27/09/2019
Presidente 01/08/2022

Precedenti posizioni note di Michael Clayman

SocietàPosizioneFine
FLEXION THERAPEUTICS, INC. Amministratore Delegato 19/11/2021
AKEBIA THERAPEUTICS, INC. Direttore/Membro del Consiglio 12/12/2018
Corporate Officer/Principal 01/01/2007
Consigliere Generale -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Michael Clayman

Formazione di Michael Clayman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

63

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Health Technology

Industrial Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Michael Clayman